封面
市场调查报告书
商品编码
1828060

2025年糖化血红素检测设备全球市场报告

Hemoglobin A1c Testing Devices Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,糖化血红素 (A1c) 检测市场快速扩张,市场规模从 2024 年的 18.8 亿美元成长至 2025 年的 20.8 亿美元,复合年增长率达 10.3%。这段历史时期的成长可归因于整体糖尿病管理方案的趋势、持续的技术创新、医疗基础设施的改善、预防性护理实践以及居家医疗。

预计未来几年,糖化血红蛋白 (A1c) 检测市场将快速成长,到 2029 年将达到 32 亿美元,年复合成长率(CAGR)为 11.4%。预测期内的成长可归因于就地检验、家庭检测和自我监测的普及、对预防性医疗保健的重视、人口老化以及医疗保健可近性的扩大。预测期内的主要趋势包括持续创新和成本效益、糖尿病盛行率上升、向就地检验的转变、技术进步以及居家医疗和自我监测。

糖化血红蛋白 (HbA1c) 检测仪是一种分析工具,用于量化糖化血红蛋白 (HbA1c)。糖化血红素是葡萄糖与血红素结合形成糖化血红素的过程,存在于个别血液样本中。其目的是持续监测血糖值,并促进高效有效的糖尿病管理。

糖化血红素 A1c 检测仪主要有两种:桌上型和手持式。桌上型设备设计用于方便在实验室工作台上使用。桌上型糖化血红素 A1c 检测仪用于实验室评估患者的血糖值,采用多种技术,包括离子交换高效液相层析法、免疫测量法、硼酸盐亲和层析法和直接酶联免疫吸附法。这些技术广泛应用于医院、製药公司、医疗设备和实验室检测。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响,尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场进入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供糖化血红蛋白 (A1c) 检测设备市场统计数据,包括全球市场规模、各地区市场份额、竞争对手的市场份额、详细的糖化血红蛋白 (A1c) 检测设备细分市场、市场趋势和商机,以及您在糖化血红蛋白 (A1c) 行业取得成功所需的设备。本糖化血红蛋白 (A1c) 检测设备市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。

未来五年的预测成长率为11.4%,较我们先前对该市场的预测略有下降0.2%。下降的主要原因是美国与其他国家之间的关税影响。这种影响可能会直接波及美国,导致硼酸亲和层析管柱和糖化血红蛋白校准品的供应链中断,这些产品主要来自加拿大和新加坡等主要地区,这可能导致糖尿病管理监测延迟和就地检验成本上升。由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响,这种影响也可能更为广泛。

糖尿病盛行率的不断上升预计将推动糖化血红蛋白 (A1c) 检测市场的成长。糖尿病是一种以血糖值升高为特征的慢性代谢性疾病。糖化血红蛋白 (A1c) 检测提供有关个人平均血糖值的重要信息,并有助于诊断 2 型糖尿病、糖尿病前期和糖尿病管理。这使患者能够监测自己的病情并做出明智的治疗决策,以预防併发症。例如,2022 年,美国国家公共卫生组织疾病管制与预防中心报告称,约有 3,730 万人(占美国人口的 11.3%)患有糖尿病。因此,糖尿病患者数量的增加将刺激糖化血红蛋白 (A1c) 检测市场的成长。

预计照护现场检验 (POC) 的便利性将推动糖化血红蛋白 (A1c) 检测市场的发展。就地检验(POCT) 是指在病人的护理点进行的检测。 POC 检测的便利性提升,使医疗保健提供者能够减少等待检测结果的漫长时间,并提高患者满意度。可携式糖化血红蛋白 (A1c) 检测设备可以在诊所、药房甚至家庭等各种环境中提供快速准确的结果。例如,根据世界卫生组织 (WHO) 制定的标准,POC 诊断方法应易于使用且易于获取,不仅适合实验室负责人使用,也适合其他接受 POC 检测基本培训的医疗专业人员使用。因此, 照护现场检测的便利性提升将有助于糖化血红蛋白 (A1c) 检测市场的成长。

糖化血红蛋白 A1c 检测设备市场涵盖自动化、半自动化和基于生物感测器的糖化血红蛋白 A1c 检测设备的销售。该市场的价值指的是“出厂价”,即商品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通膨、地缘政治、贸易战和关税,以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球糖化血红素 A1c 检测设备:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 最终用途产业分析
  • 全球糖化血红素 A1c 检测设备市场:成长率分析
  • 全球糖化血红素 A1c 检测设备市场表现:规模与成长,2019-2024 年
  • 全球糖化血红素检测设备市场预测:2024-2029年及2034年规模与成长
  • 全球糖化血红素 A1c 检测设备:总潜在市场 (TAM)

第六章 市场细分

  • 全球糖化血红素 A1c 检测设备市场:按类型、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 桌上型装置
  • 手持装置
  • 全球糖化血红素 A1c 检测设备市场:按技术、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 离子交换高效液相层析
  • 免疫检测
  • 硼酸盐亲和层析法
  • 直接酵素法
  • 其他技术
  • 全球糖化血红蛋白 A1c 检测设备市场:按最终用途、实际结果和预测,2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 製药
  • 医疗设备
  • 实验室检查
  • 全球糖化血红素 A1c 检测设备市场:按桌上型设备细分(按类型)、实际及预测,2019-2024 年、2024-2029 年、2034 年
  • 全自动糖化血红素分析仪
  • 实验室级分析设备
  • 多参数测试设备
  • 全球糖化血红素 A1c 检测设备市场:按手持设备细分(按类型)、实际及预测,2019-2024 年、2024-2029 年、2034 年
  • 可携式糖化血红素A1C测试仪
  • 就地检验设备
  • 智慧型手机综合测试装置

第七章 区域和国家分析

  • 全球糖化血红素 A1c 检测设备市场:按地区、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 全球糖化血红素 A1c 检测设备市场:依国家、绩效及预测(2019-2024 年、2024-2029 年及 2034 年)

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章:德国市场

第18章:法国市场

第十九章:义大利市场

第20章:西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第30章:竞争格局与公司概况

  • 糖化血红素检测设备市场:竞争格局
  • 糖化血红素检测设备市场:公司简介
    • Arkray Inc Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Polymer Technology Systems Inc Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc Overview, Products and Services, Strategy and Financial Analysis
    • Menarini Group Overview, Products and Services, Strategy and Financial Analysis

第31章:其他领先和创新企业

  • F Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Tosoh Corporation
  • Trinity Biotech plc
  • Transasia Bio-Medicals Limited
  • Beckman Coulter Inc
  • Diazyme Laboratories Inc
  • EKF Diagnostics Holdings plc
  • HemoCue AB
  • OSANG Healthcare Co Ltd
  • Danaher
  • Bayer AG
  • Thermo Fisher Scientific Inc.
  • PTS Diagnostics India Private Limited
  • Nova Biomedical

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章:高潜力市场国家、细分市场与策略

  • 2029 年糖化血红素检测设备市场:哪些国家将提供新机会
  • 2029 年糖化血红素检测设备市场:细分市场带来新机会
  • 2029年糖化血红素检测设备市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r23429u

The hemoglobin A1c testing device serves as the analytical tool utilized in quantifying HbA1C. In this process, glucose binds to hemoglobin, forming glycated hemoglobin within an individual's blood sample. Its purpose is to monitor blood sugar levels consistently, contributing to efficient and effective diabetic management.

Two primary types of hemoglobin A1c testing devices exist, benchtop devices and handheld devices. Benchtop devices are designed for convenient usage on a laboratory workbench. Employed in laboratories to assess blood sugar levels in patients, benchtop hemoglobin A1c testing devices make use of various technologies such as ion exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay, and others. These technologies find application in hospitals, pharmaceuticals, medical devices, and laboratory testing.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hemoglobin a1c testing devices market research report is one of a series of new reports from The Business Research Company that provides hemoglobin a1c testing devices market statistics, including hemoglobin a1c testing devices industry global market size, regional shares, competitors with a hemoglobin a1c testing devices market share, detailed hemoglobin a1c testing devices market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin a1c testing devices industry. This hemoglobin a1c testing devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemoglobin a1c testing devices market size has grown rapidly in recent years. It will grow from $1.88 billion in 2024 to $2.08 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to holistic diabetes management programs, continuous innovation, improvement in healthcare infrastructure, preventive healthcare practices, home healthcare trends.

The hemoglobin a1c testing devices market size is expected to see rapid growth in the next few years. It will grow to $3.2 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to point-of-care testing expansion, home testing and self-monitoring, focus on preventive healthcare, increasing aging population, healthcare accessibility expansion. Major trends in the forecast period include continuous innovation and cost efficiency, rising diabetes prevalence, shift towards point-of-care testing, technological advancements, home healthcare and self-monitoring.

The forecast of 11.4% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for boronate affinity chromatography columns and glycated hemoglobin calibrators, sourced from key regions such as Canada and Singapore, which could lead to slower diabetes management monitoring and increased point-of-care testing costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is anticipated to drive the growth of the hemoglobin A1C testing devices market. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels. Hemoglobin A1C testing provides crucial information regarding average blood glucose levels in individuals, aiding in the diagnosis of type 2 diabetes, pre-diabetes, and diabetes management. This enables individuals to monitor their condition and make informed treatment decisions to prevent complications. For instance, in 2022, the Centers for Disease Control and Prevention, a U.S.-based national public health agency, reported that approximately 37.3 million people, or 11.3% of the U.S. population, were affected by diabetes. Consequently, the rising number of diabetes patients will fuel the growth of the hemoglobin A1C testing devices market.

The easy accessibility of point-of-care (POC) tests is expected to boost the hemoglobin A1C testing devices market. Point-of-care testing (POCT) refers to testing conducted at the site where the patient receives medical care. With improved access to POC tests, healthcare providers can enhance patient satisfaction by reducing long wait times for test results. Portable hemoglobin A1C testing devices can deliver quick and accurate results in various settings, including doctors' offices, pharmacies, and even homes. For example, according to the standards set by the World Health Organization (WHO), POC diagnostics are user-friendly and readily accessible, suitable for use not only by laboratory personnel but also by other healthcare professionals with basic training in POC testing. Therefore, the increased accessibility of point-of-care (POC) tests will contribute to the growth of the hemoglobin A1C testing devices market.

Major companies in the hemoglobin A1C testing devices market are concentrating on developing innovative solutions, including at-home HbA1c test kits, to give patients greater control over their diabetes management. An at-home HbA1c test kit is a medical device that allows individuals to measure their hemoglobin A1c (HbA1c) levels conveniently at home. For example, in May 2022, OmegaQuant, LLC, a U.S.-based independent CLIA-certified laboratory, launched an innovative HbA1c test that enables users to monitor their blood sugar levels from home. This at-home testing kit allows individuals to collect a blood sample with a simple finger stick, providing insights into their average blood glucose levels over the past three months. The results indicate optimal ranges for healthy blood sugar management, empowering users to make informed dietary and lifestyle decisions.

Key companies in the hemoglobin A1C testing devices market are focusing on the integration of microfluidic immunofluorescence tests for hemoglobin A1C to enhance their market position. Microfluidic immunofluorescence (MIF) is a sophisticated technique that merges the principles of microfluidics and immunofluorescence to detect and quantify various biomarkers in biological samples. For instance, in May 2022, LumiraDx Limited, a London-based next-generation point-of-care diagnostics company, announced that its HbA1c test had received CE Marking. When utilized with the LumiraDx Platform, this test delivers results from a sample application in under seven minutes, allowing for rapid monitoring of diabetic patients and quick screening and identification of individuals at risk of developing the disease.

In October 2023, Abbott Laboratories, a U.S.-based medical device company, entered into a partnership with WW International. This collaboration integrates Abbott's FreeStyle Libre continuous glucose monitoring technology with WeightWatchers' diabetes-focused weight management program, offering real-time glucose insights and personalized nutritional guidance to help individuals with diabetes make informed dietary choices and improve both weight management and glycemic control. WW International, Inc. is a U.S.-based company that provides services for weight loss and maintenance, fitness, and mindset, including the comprehensive Weight Watchers diet program.

Major companies operating in the hemoglobin A1c testing devices market include Arkray Inc, Abbott Laboratories, Polymer Technology Systems Inc, Bio-Rad Laboratories Inc, Menarini Group, F Hoffmann-La Roche AG, Siemens Healthineers AG, Tosoh Corporation, Trinity Biotech plc, Transasia Bio-Medicals Limited, Beckman Coulter Inc, Diazyme Laboratories Inc, EKF Diagnostics Holdings plc, HemoCue AB, OSANG Healthcare Co Ltd, Danaher, Bayer AG, Thermo Fisher Scientific Inc., PTS Diagnostics India Private Limited, Nova Biomedical, Randox Laboratories Ltd., ACON Laboratories Inc., DiaSys Diagnostic Systems GmbH, Erba Mannheim, Green Cross Medical Science Corp., Infopia Co. Ltd., TaiDoc Technology Corporation, Werfen, Zhejiang Orient Gene Biotech Co. Ltd.

North America was the largest region in the hemoglobin A1c testing devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the hemoglobin A1c testing devices market during the forecast period. The regions covered in the hemoglobin a1c testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hemoglobin a1c testing devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemoglobin A1c testing device market consists of sales of automated, semi-automated, and bio-sensor-based hemoglobin A1c testing devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemoglobin A1c Testing Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemoglobin a1c testing devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemoglobin a1c testing devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemoglobin a1c testing devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Bench Top Device; Handheld Device
  • 2) By Technology: Ion-Exchange HPLC; Immunoassay; Boronate Affinity Chromatography; Direct Enzymatic Assay; Other Technologies
  • 3) By End Use: Hospitals; Pharmaceuticals; Medical Devices; Laboratory Testing
  • Subsegments:
  • 1) By Bench Top Device: Automated Hemoglobin A1C Analyzers; Laboratory-Grade Analyzers; Multi-Parameter Testing Devices
  • 2) By Handheld Device: Portable Hemoglobin A1C Testers; Point-Of-Care Testing Devices; Smartphone-Integrated Testing Devices
  • Companies Mentioned: Arkray Inc; Abbott Laboratories; Polymer Technology Systems Inc; Bio-Rad Laboratories Inc; Menarini Group; F Hoffmann-La Roche AG; Siemens Healthineers AG; Tosoh Corporation; Trinity Biotech plc; Transasia Bio-Medicals Limited; Beckman Coulter Inc; Diazyme Laboratories Inc; EKF Diagnostics Holdings plc; HemoCue AB; OSANG Healthcare Co Ltd; Danaher; Bayer AG; Thermo Fisher Scientific Inc.; PTS Diagnostics India Private Limited; Nova Biomedical; Randox Laboratories Ltd.; ACON Laboratories Inc.; DiaSys Diagnostic Systems GmbH; Erba Mannheim; Green Cross Medical Science Corp.; Infopia Co. Ltd.; TaiDoc Technology Corporation; Werfen; Zhejiang Orient Gene Biotech Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemoglobin A1c Testing Devices Market Characteristics

3. Hemoglobin A1c Testing Devices Market Trends And Strategies

4. Hemoglobin A1c Testing Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hemoglobin A1c Testing Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hemoglobin A1c Testing Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hemoglobin A1c Testing Devices Market Growth Rate Analysis
  • 5.4. Global Hemoglobin A1c Testing Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hemoglobin A1c Testing Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hemoglobin A1c Testing Devices Total Addressable Market (TAM)

6. Hemoglobin A1c Testing Devices Market Segmentation

  • 6.1. Global Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bench Top Device
  • Handheld Device
  • 6.2. Global Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ion-Exchange HPLC
  • Immunoassay
  • Boronate Affinity Chromatography
  • Direct Enzymatic Assay
  • Other Technologies
  • 6.3. Global Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Pharmaceuticals
  • Medical Devices
  • Laboratory Testing
  • 6.4. Global Hemoglobin A1c Testing Devices Market, Sub-Segmentation Of Bench Top Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Hemoglobin A1C Analyzers
  • Laboratory-Grade Analyzers
  • Multi-Parameter Testing Devices
  • 6.5. Global Hemoglobin A1c Testing Devices Market, Sub-Segmentation Of Handheld Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Portable Hemoglobin A1C Testers
  • Point-Of-Care Testing Devices
  • Smartphone-Integrated Testing Devices

7. Hemoglobin A1c Testing Devices Market Regional And Country Analysis

  • 7.1. Global Hemoglobin A1c Testing Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hemoglobin A1c Testing Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemoglobin A1c Testing Devices Market

  • 8.1. Asia-Pacific Hemoglobin A1c Testing Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemoglobin A1c Testing Devices Market

  • 9.1. China Hemoglobin A1c Testing Devices Market Overview
  • 9.2. China Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemoglobin A1c Testing Devices Market

  • 10.1. India Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemoglobin A1c Testing Devices Market

  • 11.1. Japan Hemoglobin A1c Testing Devices Market Overview
  • 11.2. Japan Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemoglobin A1c Testing Devices Market

  • 12.1. Australia Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemoglobin A1c Testing Devices Market

  • 13.1. Indonesia Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemoglobin A1c Testing Devices Market

  • 14.1. South Korea Hemoglobin A1c Testing Devices Market Overview
  • 14.2. South Korea Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemoglobin A1c Testing Devices Market

  • 15.1. Western Europe Hemoglobin A1c Testing Devices Market Overview
  • 15.2. Western Europe Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemoglobin A1c Testing Devices Market

  • 16.1. UK Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemoglobin A1c Testing Devices Market

  • 17.1. Germany Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemoglobin A1c Testing Devices Market

  • 18.1. France Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemoglobin A1c Testing Devices Market

  • 19.1. Italy Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemoglobin A1c Testing Devices Market

  • 20.1. Spain Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemoglobin A1c Testing Devices Market

  • 21.1. Eastern Europe Hemoglobin A1c Testing Devices Market Overview
  • 21.2. Eastern Europe Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemoglobin A1c Testing Devices Market

  • 22.1. Russia Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemoglobin A1c Testing Devices Market

  • 23.1. North America Hemoglobin A1c Testing Devices Market Overview
  • 23.2. North America Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemoglobin A1c Testing Devices Market

  • 24.1. USA Hemoglobin A1c Testing Devices Market Overview
  • 24.2. USA Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemoglobin A1c Testing Devices Market

  • 25.1. Canada Hemoglobin A1c Testing Devices Market Overview
  • 25.2. Canada Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemoglobin A1c Testing Devices Market

  • 26.1. South America Hemoglobin A1c Testing Devices Market Overview
  • 26.2. South America Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemoglobin A1c Testing Devices Market

  • 27.1. Brazil Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemoglobin A1c Testing Devices Market

  • 28.1. Middle East Hemoglobin A1c Testing Devices Market Overview
  • 28.2. Middle East Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemoglobin A1c Testing Devices Market

  • 29.1. Africa Hemoglobin A1c Testing Devices Market Overview
  • 29.2. Africa Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemoglobin A1c Testing Devices Market Competitive Landscape And Company Profiles

  • 30.1. Hemoglobin A1c Testing Devices Market Competitive Landscape
  • 30.2. Hemoglobin A1c Testing Devices Market Company Profiles
    • 30.2.1. Arkray Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Polymer Technology Systems Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bio-Rad Laboratories Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Menarini Group Overview, Products and Services, Strategy and Financial Analysis

31. Hemoglobin A1c Testing Devices Market Other Major And Innovative Companies

  • 31.1. F Hoffmann-La Roche AG
  • 31.2. Siemens Healthineers AG
  • 31.3. Tosoh Corporation
  • 31.4. Trinity Biotech plc
  • 31.5. Transasia Bio-Medicals Limited
  • 31.6. Beckman Coulter Inc
  • 31.7. Diazyme Laboratories Inc
  • 31.8. EKF Diagnostics Holdings plc
  • 31.9. HemoCue AB
  • 31.10. OSANG Healthcare Co Ltd
  • 31.11. Danaher
  • 31.12. Bayer AG
  • 31.13. Thermo Fisher Scientific Inc.
  • 31.14. PTS Diagnostics India Private Limited
  • 31.15. Nova Biomedical

32. Global Hemoglobin A1c Testing Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemoglobin A1c Testing Devices Market

34. Recent Developments In The Hemoglobin A1c Testing Devices Market

35. Hemoglobin A1c Testing Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Hemoglobin A1c Testing Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hemoglobin A1c Testing Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hemoglobin A1c Testing Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer